28851297|t|An Ag-globin G->A gene polymorphism associated with b(0)39 thalassemia globin gene and high fetal hemoglobin production.
28851297|a|BACKGROUND: Increase of the expression of g-globin gene and high production of fetal hemoglobin (HbF) in b-thalassemia patients is widely accepted as associated with a milder or even asymptomatic disease. The search for HbF-associated polymorphisms (such as the XmnI, BCL11A and MYB polymorphisms) has recently gained great attention, in order to stratify b-thalassemia patients with respect to expectancy of the first transfusion, need for annual intake of blood, response to HbF inducers (the most studied of which is hydroxyurea). METHODS: Ag-globin gene sequencing was performed on genomic DNA isolated from a total of 75 b-thalassemia patients, including 31 b(0)39/b(0)39, 33 b(0)39/b(+)IVSI-110, 9 b(+)IVSI-110/b(+)IVSI-110, one b(0)IVSI-1/b(+)IVSI-6 and one b(0)39/b(+)IVSI-6. RESULTS: The results show that the rs368698783 polymorphism is present in b-thalassemia patients in the 5'UTR sequence (+25) of the Ag-globin gene, known to affect the LYAR (human homologue of mouse Ly-1 antibody reactive clone) binding site 5'-GGTTAT-3'. This Ag(+25 G->A) polymorphism is associated with the Gg-globin-XmnI polymorphism and both are linked with the b(0)39-globin gene, but not with the b(+)IVSI-110-globin gene. In agreement with the expectation that this mutation alters the LYAR binding activity, we found that the Ag(+25 G->A) and Gg-globin-XmnI polymorphisms are associated with high HbF in erythroid precursor cells isolated from b(0)39/b(0)39 thalassemia patients. CONCLUSIONS: As a potential explanation of our findings, we hypothesize that in b-thalassemia the Gg-globin-XmnI/Ag-globin-(G->A) genotype is frequently under genetic linkage with b(0)-thalassemia mutations, but not with the b(+)-thalassemia mutation here studied (i.e. b(+)IVSI-110) and that this genetic combination has been selected within the population of b(0)-thalassemia patients, due to functional association with high HbF. Here we describe the characterization of the rs368698783 (+25 G->A) polymorphism of the Ag-globin gene associated in b(0)39 thalassemia patients with high HbF in erythroid precursor cells.
28851297	3	12	Ag-globin	GeneOrGeneProduct	3047
28851297	13	17	G->A	SequenceVariant	rs368698783
28851297	52	77	b(0)39 thalassemia globin	GeneOrGeneProduct	3043
28851297	92	108	fetal hemoglobin	GeneOrGeneProduct	3040,3048
28851297	163	171	g-globin	GeneOrGeneProduct	3047,3048
28851297	200	216	fetal hemoglobin	GeneOrGeneProduct	3040,3048
28851297	218	221	HbF	GeneOrGeneProduct	3040,3048
28851297	226	239	b-thalassemia	DiseaseOrPhenotypicFeature	D017086
28851297	240	248	patients	OrganismTaxon	9606
28851297	341	344	HbF	GeneOrGeneProduct	3040,3048
28851297	389	395	BCL11A	GeneOrGeneProduct	53335
28851297	400	403	MYB	GeneOrGeneProduct	4602
28851297	477	490	b-thalassemia	DiseaseOrPhenotypicFeature	D017086
28851297	491	499	patients	OrganismTaxon	9606
28851297	598	601	HbF	GeneOrGeneProduct	3040,3048
28851297	664	673	Ag-globin	GeneOrGeneProduct	3047
28851297	747	760	b-thalassemia	DiseaseOrPhenotypicFeature	D017086
28851297	761	769	patients	OrganismTaxon	9606
28851297	940	951	rs368698783	SequenceVariant	rs368698783
28851297	979	992	b-thalassemia	DiseaseOrPhenotypicFeature	D017086
28851297	993	1001	patients	OrganismTaxon	9606
28851297	1037	1046	Ag-globin	GeneOrGeneProduct	3047
28851297	1073	1077	LYAR	GeneOrGeneProduct	55646
28851297	1079	1084	human	OrganismTaxon	9606
28851297	1098	1103	mouse	OrganismTaxon	10090
28851297	1104	1132	Ly-1 antibody reactive clone	GeneOrGeneProduct	17089
28851297	1166	1168	Ag	GeneOrGeneProduct	3047
28851297	1169	1177	+25 G->A	SequenceVariant	rs368698783
28851297	1215	1224	Gg-globin	GeneOrGeneProduct	3048
28851297	1272	1285	b(0)39-globin	GeneOrGeneProduct	3043
28851297	1309	1328	b(+)IVSI-110-globin	GeneOrGeneProduct	3043
28851297	1399	1403	LYAR	GeneOrGeneProduct	55646
28851297	1440	1442	Ag	GeneOrGeneProduct	3047
28851297	1443	1451	+25 G->A	SequenceVariant	rs368698783
28851297	1457	1466	Gg-globin	GeneOrGeneProduct	3048
28851297	1511	1514	HbF	GeneOrGeneProduct	3040,3048
28851297	1558	1583	b(0)39/b(0)39 thalassemia	DiseaseOrPhenotypicFeature	D017086
28851297	1584	1592	patients	OrganismTaxon	9606
28851297	1674	1687	b-thalassemia	DiseaseOrPhenotypicFeature	D017086
28851297	1692	1701	Gg-globin	GeneOrGeneProduct	3048
28851297	1707	1716	Ag-globin	GeneOrGeneProduct	3047
28851297	1718	1722	G->A	SequenceVariant	rs368698783
28851297	1774	1790	b(0)-thalassemia	DiseaseOrPhenotypicFeature	D017086
28851297	1819	1835	b(+)-thalassemia	DiseaseOrPhenotypicFeature	D017086
28851297	1955	1971	b(0)-thalassemia	DiseaseOrPhenotypicFeature	D017086
28851297	1972	1980	patients	OrganismTaxon	9606
28851297	2022	2025	HbF	GeneOrGeneProduct	3040,3048
28851297	2072	2083	rs368698783	SequenceVariant	rs368698783
28851297	2085	2093	+25 G->A	SequenceVariant	rs368698783
28851297	2115	2124	Ag-globin	GeneOrGeneProduct	3047
28851297	2144	2162	b(0)39 thalassemia	DiseaseOrPhenotypicFeature	D017086
28851297	2163	2171	patients	OrganismTaxon	9606
28851297	2182	2185	HbF	GeneOrGeneProduct	3040,3048
28851297	Association	3040	4602	No
28851297	Association	3040	53335	No
28851297	Association	3040	D017086	No
28851297	Association	3048	4602	No
28851297	Association	3048	53335	No
28851297	Association	3048	3040	Novel
28851297	Association	3048	3043	Novel
28851297	Association	3048	3048	Novel
28851297	Association	3048	D017086	Novel
28851297	Association	3047	3040	Novel
28851297	Association	3047	3043	Novel
28851297	Association	3047	3048	Novel
28851297	Association	3047	17089	No
28851297	Association	3047	55646	No
28851297	Association	3047	D017086	Novel
28851297	Association	rs368698783	D017086	Novel